Michelle M. Mielke
Wake Forest University School of Medicine
Michelle M. Mielke is listed as Wake Forest University School of Medicine. Michelle is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 18 March 2027.
Compiled from published conference agendas; not yet confirmed by Michelle. Is this you? Claim this profile.
About
Michelle M. Mielke, is Chair of the Department of Epidemiology and Prevention in the Wake Forest University School of Medicine, Professor of Epidemiology, and Professor of Gerontology and Geriatric Medicine. She also directs the Real-world Advocate DAta for Research (RADAR). Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative diseases. One focus of her research is understanding the utility of blood-based biomarkers for implementation at the population-level for diagnosing Alzheimer’s disease and related dementias. Another focus of Dr. Mielke’s research is on understanding sex and gender differences in the development and progression of Alzheimer’s disease and related dementias. Dr. Mielke is PI of several NIH- and Foundation-funded clinical- and epidemiological-based grants, is a member of multiple NIH, FDA, and DoD panels, and has published over 500 peer-reviewed papers. She received the John R. Raymond Ment
Upcoming
AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027
- FROM BIOMARKERS TO DIAGNOSIS: TRANSFORMING DEMENTIA CARE Moderator · 18 March 2027
- PRECISION NEUROLOGY: MATCHING THE RIGHT DRUG TO THE RIGHT PATIENT—FROM BIOMARKERS TO CLINICAL REALITY Panellist · 19 March 2027